Lenalidomide and CC-4047 Inhibit the Proliferation of Malignant B Cells while Expanding Normal CD34+ Progenitor CellsDominique Verhelle, Kyle Chan, Helen Brady et al.|Cancer Research|2007Cited by 232
Pomalidomide and lenalidomide regulate erythropoiesis and fetal hemoglobin production in human CD34+ cellsLaure A Moutouh-de Parseval, Kyle Chan, Dominique Verhelle et al.|Journal of Clinical Investigation|2008Cited by 180
Immunomodulatory Drug CC-4047 is a Cell-type and Stimulus-Selective Transcriptional Inhibitor of Cyclooxygenase 2Gregory D. Ferguson, Kyle Chan, Kristen Jensen-Pergakes et al.|Journal of Clinical Immunology|2007Cited by 32
A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint InflammationGregory D. Ferguson, Kate Blease|PLoS ONE|2016Cited by 11
284 POSTER Lenalidomide and CC-4047 inhibit the proliferation of Namalwa cancer cells while expanding CD34+ progenitor cells. New insights on the combination therapy with HDAC inhibitors for hematological cancersDominique Verhelle, Kyle Chan, Laura G. Corral et al.|European Journal of Cancer Supplements|2006Cited by 0